CO-CREATION OF PATIENT ENGAGEMENT QUALITY GUIDANCE AND QUALITY CRITERIA FOR MEDICINES DEVELOPMENT- AN INTERNATIONAL MULTI-STAKEHOLDER INITIATIVE

Author(s)

Deane K1, Skovlund SE2, Nafria B3, Delbecque L4, Gorbenko OV5, Pakarinen C6, Brooke N7, Hamoir AM8
1University of East Anglia, Norwich, Belgium, 2Aalborg University, Aalborg, Belgium, 3Sant Joan de Déu Research Foundation, Barcelona, Spain, 4Pharmerit, International, AV Rotterdam, Belgium, 5ViiV Healthcare, Middlesex, UK, 6The Synergist, Brussels, Belgium, 7The Synergist, Bruxelles, Belgium, 8Patient Focused Medicines Development, Brussels, Belgium

OBJECTIVES: A systematic and practical guidance for patient engagement (PE) in medicines development has been identified as a priority by stakeholders. We co-created PE quality guidance (PEQG) incorporating quality criteria (PEQC) and implementation tools.

METHODS: Multi-stakeholder working groups (WGs) and task forces (TFs) were established for guidance co-creation. Published literature and existing frameworks were reviewed (2011-2016). SYNaPse (PE mapping and networking platform) was used to identify unpublished PE initiatives; initiative owners were invited to WGs/TFs. A preliminary PEQG tool (incorporating PEQC and standardised templates to allow systematic information capture for planned or ongoing/completed PE projects) was developed by TFs through an iterative process, using PE experience of participants and published material.

RESULTS: Seven WG/TF meetings were held (Nov 2016-June 2017) involving 76 participants, representing 51 organisations (including patient charities, academic researchers, funders, pharmaceutical companies). The PEQG tool was developed using published frameworks (n=6) and relevant publications (n=25) and incorporates 7 PEQC covering: [1] shared purpose; [2] respect/accessibility; [3] representativeness; [4] roles/responsibilities; [5] capacity/capability; [6] transparency; [7] continuity/sustainability. PEQG and templates were tested across WG organisations (Sept-Dec 2017), refined and released for public consultation (Dec 2017; 67 responses), and further refined and released (May 2018). We will present the PEQG tool and PEQC, public consultation results and good practice examples demonstrating each PEQC, and results from ongoing PEQG pilots.

CONCLUSIONS: The co-created PEQG tool can be used by multiple stakeholder groups and provides a practical guide to improve the quality of PE during planning and development of new projects or assess the quality and impact of ongoing/completed projects. The good practice examples provided will support PEQG implementation. We urge use of, and feedback on, the PEQG by diverse stakeholders to drive improvements in PE and allow continuous refinement of the tool.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PHP14

Topic

Health Service Delivery & Process of Care, Patient-Centered Research

Topic Subcategory

Patient Behavior and Incentives, Quality of Care Measurement

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×